Connecting you to content on EBSCOhost

Works by Du, Lillian

Results: 4

1

Long-Term Effectiveness and Safety of Ustekinumab Dose Escalation in Patients with Moderate-to-Severe Ulcerative Colitis: A Multicenter Retrospective Cohort Study.

Published in:

Digestive Diseases & Sciences, 2025, v. 70, n. 6, p. 2087, doi. 10.1007/s10620-025-08977-1

By:

van Lierop, Lisa M. A.;
Albino, Larissa;
Rosentreter, Ryan;
Thomas, Pepijn W. A.;
Lu, Cathy;
Siffledeen, Jesse;
Kroeker, Karen I.;
Ma, Christopher;
Peerani, Farhad;
Halloran, Brendan P.;
Baumgart, Daniel C.;
Dieleman, Levinus A.;
Du, Lillian;
Hoentjen, Frank;
Wong, Karen

Publication type:

Article

2

The Impact of Transitioning From Guaiac-Fecal Occult Blood Testing to Fecal Immunochemical Testing in a Canadian Colon Cancer Screening Program.

Published in:

Journal of the Canadian Association of Gastroenterology, 2020, v. 3, n. 4, p. 177, doi. 10.1093/jcag/gwz009

By:

Sultanian, Richard;
Du, Lillian;
Moysey, Barbara;
Morse, Amy;
Zanten, Sander Veldhuyzen van;
Montano-Loza, Aldo J

Publication type:

Article

3

Hypoalbuminaemia and Postoperative Outcomes in Inflammatory Bowel Disease: the NSQIP Surgical Cohort.

Published in:

Journal of Crohn's & Colitis, 2019, v. 13, n. 11, p. 1433, doi. 10.1093/ecco-jcc/jjz083

By:

Nguyen, Geoffrey C;
Du, Lillian;
Chong, Rachel Y;
Jackson, Timothy D

Publication type:

Article

4

Serum IgG4 cut-off of 70 mg/dL is associated with a shorter time to cirrhosis decompensation and liver transplantation in primary sclerosing cholangitis patients.

Published in:

Canadian Liver Journal, 2022, v. 5, n. 1, p. 31, doi. 10.3138/canlivj-2021-0023

By:

Peerani, Farhad;
Du, Lillian;
Lytvyak, Ellina;
Bain, Vincent G.;
Mason, Andrew L.;
Bailey, Robert J.;
Montano-Loza, Aldo J.

Publication type:

Article